Literature DB >> 1573388

Humoral immunity to respiratory syncytial virus infection in the elderly.

A R Falsey1, E E Walsh.   

Abstract

The relationship between serum immunoglobulins and the severity and risk of Respiratory Syncytial Virus (RSV) infection in the institutionalized elderly was prospectively assessed during the winter of 1989-1990 at a 591 bed nursing home. Forty RSV infections were identified out of 149 respiratory illnesses by isolation of the virus or by a greater than or equal to 4-fold rise in RSV-specific IgG by EIA. Acute serum RSV IgG levels were similar in those with RSV infection and those with non-RSV illness. Additionally, among the RSV-infected elderly there was no correlation between severity of clinical symptoms and level of acute IgG titers by EIA or virus neutralization. The results of this study suggest that humoral immunity does not play a major role in reducing the risk of infection nor modulating the clinical severity of illness in elderly persons with RSV infections.

Entities:  

Mesh:

Year:  1992        PMID: 1573388     DOI: 10.1002/jmv.1890360108

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

1.  Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein.

Authors:  Yoshihiko Murata; Paula M Lightfoote; Jamie N Biear; Ann R Falsey; Edward E Walsh
Journal:  Vaccine       Date:  2010-07-23       Impact factor: 3.641

Review 2.  Respiratory syncytial virus infection in adults.

Authors:  A R Falsey; E E Walsh
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

Review 3.  Respiratory syncytial virus infection in the elderly.

Authors:  G Mlinaric-Galinovic; A R Falsey; E E Walsh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-10       Impact factor: 3.267

4.  Targeting CD137 enhances vaccine-elicited anti-respiratory syncytial virus CD8+ T cell responses in aged mice.

Authors:  Sujin Lee; Robert S Mittler; Martin L Moore
Journal:  J Immunol       Date:  2013-11-27       Impact factor: 5.422

5.  Age-associated aggravation of clinical disease after primary metapneumovirus infection of BALB/c mice.

Authors:  M Darniot; C Pitoiset; T Petrella; S Aho; P Pothier; C Manoha
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

6.  Influence of respiratory syncytial virus strain differences on pathogenesis and immunity.

Authors:  José A Melero; Martin L Moore
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

Review 7.  Respiratory syncytial virus infections in the adult asthmatic--mechanisms of host susceptibility and viral subversion.

Authors:  Blair D Westerly; R Stokes Peebles
Journal:  Immunol Allergy Clin North Am       Date:  2010-09-22       Impact factor: 3.479

8.  Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein.

Authors:  Bert Schepens; Koen Sedeyn; Liesbeth Vande Ginste; Sarah De Baets; Michael Schotsaert; Kenny Roose; Lieselot Houspie; Marc Van Ranst; Brian Gilbert; Nico van Rooijen; Walter Fiers; Pedro Piedra; Xavier Saelens
Journal:  EMBO Mol Med       Date:  2014-11       Impact factor: 12.137

9.  Restoration of Retarded Influenza Virus-specific Immunoglobulin Class Switch in Aged Mice.

Authors:  Yongxin Zhang; Ying Wang; Monica Zhang; Lin Liu; Innocent N Mbawuike
Journal:  J Clin Cell Immunol       Date:  2016-03-22

10.  Protection against respiratory syncytial virus infection by DNA immunization.

Authors:  X Li; S Sambhara; C X Li; M Ewasyshyn; M Parrington; J Caterini; O James; G Cates; R P Du; M Klein
Journal:  J Exp Med       Date:  1998-08-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.